6-Ketoprostaglandin F1 alpha
"6-Ketoprostaglandin F1 alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.
| Descriptor ID |
D015121
|
| MeSH Number(s) |
D10.251.355.255.550.400.350 D10.251.355.325.450 D23.469.050.175.725.400.350
|
| Concept/Terms |
6-Ketoprostaglandin F1 alpha- 6-Ketoprostaglandin F1 alpha
- F1 alpha, 6-Ketoprostaglandin
- alpha, 6-Ketoprostaglandin F1
- 6-Oxoprostaglandin F1 alpha
- 6 Oxoprostaglandin F1 alpha
- F1 alpha, 6-Oxoprostaglandin
- alpha, 6-Oxoprostaglandin F1
- 6-Oxo-PGF1 alpha
- 6 Oxo PGF1 alpha
- alpha, 6-Oxo-PGF1
- 6 Ketoprostaglandin F1 alpha
- 6-Keto-PGF1 alpha
- 6 Keto PGF1 alpha
- alpha, 6-Keto-PGF1
|
Below are MeSH descriptors whose meaning is more general than "6-Ketoprostaglandin F1 alpha".
Below are MeSH descriptors whose meaning is more specific than "6-Ketoprostaglandin F1 alpha".
This graph shows the total number of publications written about "6-Ketoprostaglandin F1 alpha" by people in this website by year, and whether "6-Ketoprostaglandin F1 alpha" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "6-Ketoprostaglandin F1 alpha" by people in Profiles.
-
Pi F, Hotter G, Closa D, Prats N, Fern?ndez-Cruz L, Badosa F, Gelpi E, Rosell?-Catafau J. Differential effect of nitric oxide inhibition as a function of preservation period in pancreas transplantation. Dig Dis Sci. 1997 May; 42(5):962-71.
-
Hotter G, Closa D, Pi F, Rosell?-Catafau J, Bulbena O, Badosa F, Fern?ndez-Cruz L, Gelp? E. Arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. J Lipid Mediat Cell Signal. 1994 Mar; 9(2):135-43.
-
Kirton OC, Jones RC, Carvalho AC. Thromboxane and prostacyclin release after endotoxin infusion in the rat. Intensive Care Med. 1990; 16(7):436-40.
-
Kirton OC, Jones R. Rat pulmonary artery restructuring and pulmonary hypertension induced by continuous Escherichia coli endotoxin infusion. Lab Invest. 1987 Feb; 56(2):198-210.
-
Prosdocimi M, Finesso M, Tessari F, Gorio A, Languino LR, de Gaetano G, Dejana E. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. Thromb Res. 1985 Aug 15; 39(4):399-409.
-
Prosdocimi M, Finesso M, Gorio A, Languino LR, Del Maschio A, Castagnoli MN, De Gaetano G, Dejana E. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog. Am J Physiol. 1985 Apr; 248(4 Pt 2):H493-9.
-
Prosdocimi M, Tessari F, Finesso M, Gorio A, Dejana E, Languino LR, Del Maschio A, de Gaetano G. Prostacyclin and thromboxane levels during cardiac ischemia in dogs. Adv Prostaglandin Thromboxane Leukot Res. 1985; 13:93-6.
-
Kirton OC, Jones R, Zapol WM, Reid L. The development of a model of subacute lung injury after intra-abdominal infection. Surgery. 1984 Aug; 96(2):384-94.
-
Jaweed MM, Alam I, Herbison GJ, Ditunno JF. Changes in thromboxane B2 and 6-keto-PGF1 alpha after direct electrical stimulation of the denervated rat gastrocnemius1,2. Prostaglandins Leukot Med. 1982 Aug; 9(2):205-10.